PTCT

PTC Therapeutics
PTCT

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$3.95B
EV
$4.40B
Shares Outstanding
80.48M
Beta
0.51

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$62.81
P/E 2025E
8.13x
P/Revenue 2025E
2.42x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About PTC Therapeutics, Inc.

gainify
PTCT

PTC Therapeutics, Inc.

PTCT

PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders in the United States and internationally. The company offers Translarna and Emflaza for the treatment of Duch...

Sector

Healthcare

Industry

Biotechnology

CEO

Klein, Matthew

Employees

939

IPO Date

2013-06-20

Headquarters

100 Corporate Court, South Plainfield, New Jersey, 07080, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.